All articles by Manish Kumar
Manish Kumar
Fujifilm launches new ECHELON Synergy 1.5T MRI system software with AI powered workflow enhancements
Software is designed to address long-standing pain points of MRI with new deep learning reconstruction, artifact and motion correction technologies
Medtronic reports positive results from Symplicity Spyral system trial
The healthcare technology company is also advancing clinical data for the Symplicity Spyral system through the SPYRAL Gemini trial and expanding the GSR-DEFINE trial
Distalmotion gets FDA De Novo marketing nod for Dexter Surgical Robot
Dexter offers robotic surgery benefits to hospitals and outpatient centres with its simple, modular design to enhance accessibility and ease of use for medical teams
Scottish tech company Novosound develops world’s first ultrasound blood pressure monitor
Novosound now poised to revolutionize blood pressure monitoring in wearables
BioPorto enters global distribution partnership with Beckman Coulter for acute kidney injury NGAL tests
Beckman Coulter will distribute BioPorto’s neutrophil gelatinase-associated lipocalin (NGAL) tests for use on Beckman Coulter family of DxC and AU clinical chemistry analyzers
Adona starts FIH trial of interatrial shunt in heart failure patients
The device features an adjustable shunt and integrated bi-atrial pressure monitoring sensors for personalised heart failure treatment and improved patient management
Advanced Nanotherapies reports positive data from trial of SirPlux Duo DCB
The company also announced plans to start a US early feasibility study of its investigational dual-drug therapy designed for treating coronary de novo disease
Inspira announces establishment of distribution facility to support US deployment of INSPIRA ART100
The Company has signed a distribution agreement that assigns to Glo-Med the role of Inspira’s primary distributor and customer support center in the US
Helio Genomics and Halub Medical announce strategic partnership to commercialise HelioLiver Dx in The Gulf Cooperation Council and Middle East
The test is expected to be commercially available in Saudi Arabia and The Gulf Cooperation Council (GCC) in Q1 2025, with the following 12-month revenue for Helio expected to exceed $10 million dollars
Abbott to start CardioMEMS HF System trial for heart failure patients
The trial will use Abbott’s CardioMEMS HF System on 850 patients globally to measure pulmonary artery pressures and identify high-risk advanced heart failure patients